Press On is pleased to announce the formation of a Medical Advisory Board. The Press On Medical Advisory Board (MAB) is comprised of leading experts in their fields. The MAB’s role is to advise the Press On Board on a range of issues and to provide scientific review of research proposals to ensure that the research programs funded by Press On are scientifically sound and specific to our missions of curing childhood cancer, with a focus on therapies that are less toxic and have fewer long-term side affects. The members of the Press On Medical Advisory Board, in alphabetical order, are:

William E. Evans, M.D.

Endowed Chair in Pharmacogenomics, St. Jude Children’s Research Hospital
Director, 2004-2014, St. Jude  Children’s Research Hospital
Chair, 1986-2002, St. Jude Department of Pharmaceutical Sciences
St. Jude Children’s Research Hospital

Kelly Goldsmith, M.D.

Director, MIBG Program
Pediatric Hematology/ Oncology
Assistant Professor of Pediatrics, Children’s Healthcare of Atlanta

Howard Katzenstein, M.D.

Professor of Pediatrics, Vanderbilt University
Scott and Tracie Hamilton Chair in Cancer Survivorship
Medical Director, Pediatric Hematology Oncology, Vanderbilt University

Samir Khleif, M.D.

Director, GRU Cancer Center Member, Cancer Immunology, Inflammation & Tolerance
Professor of Biochemistry, Molecular Biology Professor of Graduate Studies, Georgia Regents University

John M. Maris, M.D.

Giulio D’Angio Endowed Professor of Pediatrics
Director, Center for Childhood Cancer Research
Children’s Hospital of Philadelphia
Perelman School of Medicine at the University of Pennsylvania

Jeffrey Rubnitz, M.D., Ph.D

Division Chief, Leukemia and Lymphoma Division
St. Jude Children’s Research Hospital